VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $31,236,000 | +14.7% | 814,500 | -4.2% | 3.61% | -32.4% |
| Q4 2021 | $27,226,000 | -8.0% | 850,000 | -15.4% | 5.35% | +6.3% |
| Q3 2021 | $29,609,000 | -13.3% | 1,004,700 | 0.0% | 5.03% | -46.6% |
| Q2 2021 | $34,140,000 | +5.0% | 1,004,700 | +0.5% | 9.43% | -24.0% |
| Q1 2021 | $32,500,000 | +10.2% | 1,000,000 | +22.1% | 12.40% | +4.0% |
| Q4 2020 | $29,502,000 | +123.8% | 819,054 | +143.4% | 11.92% | +187.3% |
| Q3 2020 | $13,180,000 | +86.1% | 336,554 | +74.3% | 4.15% | +21.4% |
| Q2 2020 | $7,083,000 | +85.1% | 193,116 | +16.3% | 3.42% | +169.6% |
| Q1 2020 | $3,827,000 | -6.7% | 166,116 | +18.6% | 1.27% | -45.3% |
| Q4 2019 | $4,103,000 | – | 140,116 | – | 2.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |